论文信息 - A Phase II Study of Isatuximab, Once Weekly Carfilzomib, Lenalidomide, Dexamethasone, in Newly Diagnosed, Transplant-Eligible Multiple Myeloma (The SKylaRk Trial) - 字舞流文

A Phase II Study of Isatuximab, Once Weekly Carfilzomib, Lenalidomide, Dexamethasone, in Newly Diagnosed, Transplant-Eligible Multiple Myeloma (The SKylaRk Trial)

J. Laubach | O. Nadeem | A. Branagan | D. Cirstea | J. Rosenblatt | C. Mo | Andrew J. Yee | N. Raje | Elizabeth K O'Donnell | Paul G Richardson | Nora Horick